A specific field or category within healthcare that focuses on the diagnosis, treatment, and management of a particular set of medical conditions or diseases.

Indication:

A specific medical condition or disease for which a particular therapy, drug, or intervention is approved and intended to treat.

Pipeline:

The collection of drugs or therapies that a pharmaceutical company is currently developing or testing for potential use in a specific therapy area.

First-Line Treatment:

The initial therapy prescribed for a particular condition, often considered the most effective or commonly used as a starting point in treatment.

Adjuvant Therapy:

Additional treatment given after the primary therapy, usually to enhance the effectiveness of the main treatment or reduce the risk of recurrence.

Standard of Care:

The established and widely accepted treatment protocols or approaches for a specific therapy area, based on current medical knowledge and guidelines.

Breakthrough Therapy:

A new treatment or drug that demonstrates significant improvement over existing therapies for a particular condition, often fast-tracked for approval by regulatory authorities.

Off-Label Use:

The use of a drug or therapy to treat a medical condition not specifically approved by regulatory authorities, but within the bounds of accepted medical practice.

Personalized Medicine:

Tailoring medical treatment to the individual characteristics of each patient, often involving genetic or molecular information to determine the most effective therapy.

Biologics:

Therapeutic substances derived from living organisms, such as antibodies or proteins, used to treat specific conditions within a therapy area.